4. 原発性側索硬化症 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 6 / 薬物数 : 10 - (DrugBank : 6) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 27

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Dalfampridine
   Hospital for Special Surgery, New York
      2016   Phase 1   NCT02868567   United States
Daraprim
   Weill Medical College of Cornell University
      2013   -   EUCTR2011-004798-99-DE   Germany;Italy;United States
Dexdor
   Turku University Hospital
      2018   Phase 4   EUCTR2018-000142-18-FI   Finland
Dexmedetomidine
   Turku University Hospital
      2018   Phase 4   EUCTR2018-000142-18-FI   Finland
Esketamine
   Turku University Hospital
      2018   Phase 4   EUCTR2018-000142-18-FI   Finland
HB-admscs
   Hope Biosciences Stem Cell Research Foundation
      2021   -   NCT04825613   United States
Ketanest-S
   Turku University Hospital
      2018   Phase 4   EUCTR2018-000142-18-FI   Finland
Levetiracetam
   Duke University
      2006   Phase 2   NCT00324454   United States
Pyrimethamine
   Weill Medical College of Cornell University
      2013   -   EUCTR2011-004798-99-DE   Germany;Italy;United States
Stem cells
   Stem Cells Arabia
      2016   Phase 1/Phase 2   NCT03067857   -